Ignite Creation Date:
2024-05-06 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03642236
Status:
UNKNOWN
Last Update Posted:
2018-08-22
First Post:
2018-08-20
Brief Title:
Combination of BTK Inhibitor Overcomes Drug-resistance in RefractoryRelapsed FLT3 Mutant AML
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-20
First Submit QC Date:
August 20 2018
Study First Post Date:
2018-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-20
Last Update Post Date:
2018-08-22
Last Update Post Date Type:
ACTUAL